Hi Russ, I may be a bit late to this thread, but infusion start dates will be helpful with regards to use of targeted therapies for patients in our cohorts. However, if we intend/desire to track completion of therapy or cessation of therapy for any reason, the end dates will become important.
W. Scott Campbell, PhD, MBA Assistant Professor Director of Public Health Laboratory Informatics and Pathology Laboratory Informatics Department of Pathology/Microbiology University of Nebraska Medical Center 985900 Nebraska Medical Center Omaha NE 68198-5900 402-559-9593 (office) 402-350-7851 (mobile) ________________________________ From: Gpc-rcr <gpc-rcr-boun...@listserv.kumc.edu> on behalf of Russ Waitman <rwait...@kumc.edu> Sent: Monday, October 9, 2017 10:28 AM To: 'Marsolo, Keith' Cc: PCORnet DRN OC (dr...@pcornet.org); Lesley Curtis; GPC-DEV@LISTSERV.KUMC.EDU; Rapid Cycle Research Listserv (gpc-...@listserv.kumc.edu) Subject: Re: [Gpc-rcr] using Cancer RCR project for testing CDM 4.0 med admin table Non-UNMC email Thanks Keith, As we discussed at the Data Committee meeting on Friday, we’ll see if we can pilot using the new MED_ADMIN table but recognize that in the current draft there’s no “end date” for say an infusion. Betsy and Iowa team: do you think for this specific RCR project, end date for med_admin is essential or will just knowing the admin as a start_date will be sufficient. We could either use the MED_ADMIN table as is or add a column for this study to contain the end date of the infusion. Russ From: Marsolo, Keith [mailto:keith.mars...@cchmc.org] Sent: Wednesday, October 04, 2017 9:08 AM To: Russ Waitman Cc: PCORnet DRN OC (dr...@pcornet.org); Lesley Curtis; McDowell, Bradley D; Chrischilles, Elizabeth A; Gryzlak, Brian M; nicholas-c-sm...@uiowa.edu Subject: Re: using Cancer RCR project for testing CDM 4.0 med admin table Russ, You can start with me and then we’ll rope in others as needed. Thanks. Keith On Oct 3, 2017, at 2:08 PM, Russ Waitman <rwait...@kumc.edu<mailto:rwait...@kumc.edu>> wrote: Hi Keith, Lesley, and DRNOC, We’re working with Iowa who’s leading our Rapid Cycle Research project to understand the degree of completeness in molecular diagnostic testing and targeted therapeutics for solid tumors. One area we’ll uncover is variability in medication administration/infusion. We thought that give we have a CDM 4.0 draft which now has a med administration home, we might pilot populating that table as part of the project to develop best practices. Is there someone you would recommend we engage with from DRNOC in testing and developing those practices? Sincerely, Russ Waitman, PhD Director of Medical Informatics Associate Vice Chancellor for Enterprise Analytics Professor, Department of Internal Medicine University of Kansas Medical Center, Kansas City, Kansas 913-945-7087 (office) rwait...@kumc.edu<mailto:rwait...@kumc.edu> http://www.kumc.edu/ea-mi/ http://informatics.kumc.edu<http://informatics.kumc.edu/> http://www.gpcnetwork.org<http://www.gpcnetwork.org/> – a PCORnet collaborative www.pcornet.org<http://www.pcornet.org/> The information in this e-mail may be privileged and confidential, intended only for the use of the addressee(s) above. Any unauthorized use or disclosure of this information is prohibited. If you have received this e-mail by mistake, please delete it and immediately contact the sender.
_______________________________________________ Gpc-dev mailing list Gpc-dev@listserv.kumc.edu http://listserv.kumc.edu/mailman/listinfo/gpc-dev
